Fluxion Biosciences announced today that the Karp Laboratory at the Brigham and Women's Hospital (BWH) has purchased the BioFlux 1000 system, which will be applied in their stem cell homing research.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50 th American Society for Cell ...

REDWOOD CITY, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has received a 510(k) ...

Fluxion Biosciences have announced the commercial launch of its BioFlux platform, which provides automated biofilm analysis for disease research and drug discovery applications. Biofilms are bacterial ...

Fluxion Biosciences announced that its BioFlux system was used in research on COVID-19 and its ability to lead to high levels of platelet coagulation and an increased risk of thrombosis. The first ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences announced today that the Karp Laboratory at the Brigham and Women’s Hospital (BWH) has purchased the BioFlux 1000 system, which will ...

REDWOOD CITY, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the launch of its Bioflux® ...

Many physiological processes take place under flow conditions: blood flowing through the vasculature, cells migrating through the endothelium, and biofilms forming in tissue. BioFlux shear flow ...

REDWOOD CITY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric ...

Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50 th American Society for Cell Biology Annual Meeting to be held December 11-15, ...